{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T02:38:17Z","timestamp":1761187097658,"version":"build-2065373602"},"reference-count":103,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Interuniversity Consortium for Biotechnologies, Italy","award":["CIB-MUR-Unife2024"],"award-info":[{"award-number":["CIB-MUR-Unife2024"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Cystic fibrosis (CF) is an inherited genetic disease caused by dysregulation of the cystic fibrosis transmembrane regulator (CFTR) gene, a chronic hyperinflammatory state and frequently occurring severe bacterial infections of the lungs. Novel protocols for treating CF inflammation are highly needed. Among the most interesting fields of pre-clinical investigation, the use of natural products, including those used in ethnopharmacology, appears to be promising. Examples of natural ethnopharmacological products that should be further investigated as potential anti-inflammatory agents for CF include inhibitors of the Toll-like receptor 4 (TLR4)\/Nuclear Factor \u03baB (TLR4\/NF\u03baB) pathway, such as parthenolide, curcumin and garlic-related constituents. In addition, \u201cmiRNA therapeutics\u201d protocols have been reported as able to dampen the expression of pro-inflammatory genes. These two fields of investigation deserve, in the near future, further experimental efforts. Notably, these two approaches can be combined in order to develop novel strategies to improve the inhibitory activity on the expression of key pro-inflammatory genes activated in cystic fibrosis, including those induced by Pseudomonas aeruginosa infection.<\/jats:p>","DOI":"10.3390\/molecules30214155","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T02:03:48Z","timestamp":1761185028000},"page":"4155","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Future Perspectives on Targeting the Activated TLR4\/NF\u03baB Pathway in Cystic Fibrosis: A Possible Interplay Between Ethnopharmacology and microRNA Therapeutics"],"prefix":"10.3390","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9205-6033","authenticated-orcid":false,"given":"Roberto","family":"Gambari","sequence":"first","affiliation":[{"name":"Department of Life Sciences and Biotechnology, Ferrara University, I-44121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7638-515X","authenticated-orcid":false,"given":"Alessia","family":"Finotti","sequence":"additional","affiliation":[{"name":"Department of Life Sciences and Biotechnology, Ferrara University, I-44121 Ferrara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1056\/NEJMra043184","article-title":"Cystic fibrosis","volume":"352","author":"Rowe","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"005","DOI":"10.1385\/CRIAI:23:1:005","article-title":"The role of inflammation in the pathophysiology of CF lung disease","volume":"23","author":"Chmiel","year":"2002","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jcf.2015.03.003","article-title":"Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy","volume":"14","author":"Cantin","year":"2015","journal-title":"J. Cyst. Fibros."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.JAA.0000515540.36581.92","article-title":"Keep them breathing: Cystic fibrosis pathophysiology, diagnosis, and treatment","volume":"30","author":"Brown","year":"2017","journal-title":"JAAPA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev-med-112717-094536","article-title":"Cystic Fibrosis: Emerging Understanding and Therapies","volume":"70","author":"Rey","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"ref_6","first-page":"13","article-title":"Toll-like receptors 4 and 2 ex-pression in the bronchial mucosa of patients with cystic fibrosis","volume":"12","author":"Hauber","year":"2005","journal-title":"Can. Respir. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.4049\/jimmunol.174.3.1638","article-title":"TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells","volume":"174","author":"Greene","year":"2005","journal-title":"J. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/ajplung.2001.281.1.L69","article-title":"Dysregulated NF-kappaB activation in cystic fibrosis: Evidence for a primary inflammatory disorder","volume":"281","author":"Blackwell","year":"2001","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jcf.2010.11.005","article-title":"aeruginosa drives CXCL8 synthesis via redundant toll-like receptors and NADPH oxidase in CFTR\u2206F508 airway epithelial cells","volume":"10","author":"Roussel","year":"2010","journal-title":"J. Cyst. Fibrosis"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"6990","DOI":"10.4049\/jimmunol.1100396","article-title":"Abnormal trafficking and degradation of TLR4 underlie the elevated inflammatory response in cystic fibrosis","volume":"186","author":"Bruscia","year":"2011","journal-title":"J. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tibs.2011.11.003","article-title":"Different dimerisation mode for TLR4 upon endosomal acidification?","volume":"37","author":"Gangloff","year":"2012","journal-title":"Trends Biochem. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","article-title":"TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling","volume":"78","author":"Ciesielska","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-0-387-71767-8_4","article-title":"The journey of Toll-like receptors in the cell","volume":"598","author":"Halaas","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"L371","DOI":"10.1152\/ajplung.00372.2011","article-title":"Toll-like receptor 4 is not targeted to the lysosome in cystic fibrosis airway epithelial cells","volume":"304","author":"Kelly","year":"2013","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fimmu.2014.00071","article-title":"Regulation of the NF-\u03baB-Mediated Transcription of Inflammatory Genes","volume":"5","author":"Bhatt","year":"2014","journal-title":"Frontiers Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/0113892037324425241018061548","article-title":"TLR4 Targeting: A Promising Therapeutic Approach Across Multiple Human Diseases","volume":"16","author":"Kumar","year":"2025","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: New in-sights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1039\/c3cs60039d","article-title":"Targeting Toll-like receptors with small molecule agents","volume":"42","author":"Wang","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1021\/acs.accounts.9b00631","article-title":"Small-Molecule Modulators of Toll-like Receptors","volume":"53","author":"Wang","year":"2020","journal-title":"Acc. Chem. Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Wei, J., Zhang, Y., Li, H., Wang, F., and Yao, S. (2023). Toll-like receptor 4: A potential therapeutic target for multiple human diseases. Biomed. Pharmacother., 166.","DOI":"10.1016\/j.biopha.2023.115338"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/13543776.2016.1185415","article-title":"Recent progress in the development of Toll-like receptor (TLR) antagonists","volume":"26","author":"Patra","year":"2016","journal-title":"Expert. Opin. Ther. Patents"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"120359","DOI":"10.1016\/j.jep.2025.120359","article-title":"Harnessing the potential of ethnopharmacology for future medicines","volume":"353","author":"Patwardhan","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2008.01.026","article-title":"TAK-242 selectively suppresses toll-like receptor 4-signaling mediated by the intracellular domain","volume":"584","author":"Kawamoto","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1124\/mol.110.068064","article-title":"TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules","volume":"79","author":"Matsunaga","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1476-5381.2009.00297.x","article-title":"Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model","volume":"157","author":"Takashima","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13075-020-2097-2","article-title":"Investigation of toll-like receptor (TLR) 4 inhibitor TAK-242 as a new potential anti-rheumatoid arthritis drug","volume":"22","author":"Samarpita","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1017\/S1368980000000598","article-title":"The efficacy and safety of feverfew (Tanacetum parthenium L.): An update of a systematic review","volume":"3","author":"Ernst","year":"2000","journal-title":"Public. Health Nutr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/014107688808100701","article-title":"Feverfew\u2014An ancient remedy for modern times","volume":"81","author":"Heptinstall","year":"1988","journal-title":"J. R. Soc. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1146\/annurev.pharmtox.38.1.539","article-title":"Ethnopharmacology of Mexican asteraceae (Compositae)","volume":"38","author":"Heinrich","year":"1998","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10059-011-0032-8","article-title":"Parthenolide inhibits TRIF-dependent signaling pathway of Toll-like receptors in RAW264.7 macrophages","volume":"31","author":"Park","year":"2011","journal-title":"Mol. Cells"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/abbs\/gmv019","article-title":"Parthenolide inhibits LPS-induced inflammatory cytokines through the toll-like receptor 4 signal pathway in THP-1 cells","volume":"47","author":"Li","year":"2015","journal-title":"Acta Biochim. Et Biophys. Sin."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1165\/rcmb.2006-0323OC","article-title":"Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and in-flammatory response in cystic fibrosis cells and mice","volume":"36","author":"Saadane","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1002\/jsfa.14193","article-title":"Brassica oleracea as a functional crop: Phytochemical potential and sustainable applications","volume":"105","author":"Rasane","year":"2025","journal-title":"J. Sci. Food Agric."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Alves, I., Ara\u00fajo, E.M.Q., Dalgaard, L.T., Singh, S., B\u00f8rsheim, E., and Carvalho, E. (2025). Protective Effects of Sulforaphane Preventing In-flammation and Oxidative Stress to Enhance Metabolic Health: A Narrative Review. Nutrients, 17.","DOI":"10.3390\/nu17030428"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Barali\u0107, K., \u017divanovi\u0107, J., Mari\u0107, \u0110., Bo\u017ei\u0107, D., Grahovac, L., Miljakovi\u0107, E.A., \u0106ur\u010di\u0107, M., Djordjevi\u0107, A.B., Bulat, Z., and Antonijevi\u0107, B. (2024). Sulforaphane\u2014A Compound with Potential Health Benefits for Disease Prevention and Treatment: Insights from Pharmacological and Toxicological Experimental Studies. Antioxidants, 13.","DOI":"10.3390\/antiox13020147"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.bbrc.2013.03.123","article-title":"Sulforaphane inhibits the engagement of LPS with TLR4\/MD2 complex by preferential binding to Cys133 in MD2","volume":"434","author":"Koo","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1620\/tjem.2024.J105","article-title":"Sulforaphane Inhibits LPS-induced Macrophage PANoptosis via TLR4\/NFB Pathway: A Potential Therapeutic Strategy for Acute Lung Injury","volume":"265","author":"Wang","year":"2025","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Hewlings, S.J., and Kalman, D.S. (2017). Curcumin: A Review of Its Effects on Human Health. Foods, 6.","DOI":"10.3390\/foods6100092"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/acs.jmedchem.6b00975","article-title":"The Essential Medicinal Chemistry of Curcumin","volume":"60","author":"Nelson","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"100222","DOI":"10.1016\/j.prmcm.2023.100222","article-title":"Curcuma longa (Turmeric): Ethnomedicinal uses, phytochemistry, pharmacological activities and toxicity profiles\u2014A review","volume":"6","author":"Iweala","year":"2023","journal-title":"Pharmacol. Res. Mod. Chin. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2174\/1381612825666190402163940","article-title":"Ethnobotany, Phytochemistry and Traditional Uses of Curcuma spp. and Pharmacological Profile of Two Important Species (C. longa and C. zedoaria): A Review","volume":"25","author":"Ayati","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4973128","DOI":"10.1155\/2016\/4973128","article-title":"Two Traditional Chinese Medicines Curcumae Radix and Curcumae Rhizoma: An Ethnopharmacology, Phytochemistry, and Pharmacology Review","volume":"2016","author":"Zhou","year":"2016","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Panaro, M.A., Corrado, A., Benameur, T., Paolo, C.F., Cici, D., and Porro, C. (2020). The Emerging Role of Curcumin in the Modulation of TLR-4 Signaling Pathway: Focus on Neuroprotective and Anti-Rheumatic Properties. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072299"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fphar.2016.00369","article-title":"Curcumin Represses NLRP3 Inflammasome Activation via TLR4\/MyD88\/NF-\u03baB and P2X7R Signaling in PMA-Induced Macrophages","volume":"7","author":"Kong","year":"2016","journal-title":"Frontiers Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/aps.2013.24","article-title":"Curcumin inhibits LPS-induced inflammation in rat vascular smooth muscle cells in vitro via ROS-relative TLR4-MAPK\/NF-\u03baB pathways","volume":"34","author":"Meng","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"155423","DOI":"10.1016\/j.prp.2024.155423","article-title":"Liposomal curcumin inhibits cigarette smoke induced senescence and inflammation in human bronchial epithelial cells","volume":"260","author":"Kokkinis","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Leon-Icaza, S.A., Fr\u00e9taud, M., Corn\u00e9lie, S., Bureau, C., Yatime, L., Floto, R.A., Renshaw, S.A., Herrmann, J.-L., Langevin, C., and Cougoule, C. (2025). Curcumin-mediated NRF2 induction limits inflammatory damage in, preclinical models of cystic fibrosis. Biomed. Pharmacother., 186.","DOI":"10.1016\/j.biopha.2025.117957"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"L380","DOI":"10.1152\/ajplung.00129.2010","article-title":"Trimethylangelicin reduces IL-8 transcrip-tion and potentiates CFTR function","volume":"300","author":"Tamanini","year":"2011","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Laselva, O., Marzaro, G., Vaccarin, C., Lampronti, I., Tamanini, A., Lippi, G., Gambari, R., Cabrini, G., Bear, C.E., and Chilin, A. (2018). Molecular Mechanism of Action of Trimethylangelicin Derivatives as CFTR Modulators. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.00719"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejmech.2018.03.080","article-title":"Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB)","volume":"151","author":"Marzaro","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.febslet.2004.06.056","article-title":"Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-\u03baB without affecting I\u03baB degradation","volume":"571","author":"Shin","year":"2004","journal-title":"Febs Lett."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1183\/09031936.00032412","article-title":"Expression of the nuclear factor-\u03baB inhibitor A20 is altered in the cystic fibrosis epithelium","volume":"41","author":"Kelly","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-2006-959522","article-title":"Antioxidant and radical scavenging effects of aged garlic ex-tract and its constituents","volume":"60","author":"Imai","year":"1994","journal-title":"Planta Medica"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Serrano, J.C.E., Castro-Boqu\u00e9, E., Garc\u00eda-Carrasco, A., Mor\u00e1n-Valero, M.I., Gonz\u00e1lez-Hedstr\u00f6m, D., Berm\u00fadez-L\u00f3pez, M., Valdivielso, J.M., Espinel, A.E., and Portero-Ot\u00edn, M. (2023). Antihypertensive Effects of an Optimized Aged Garlic Extract in Subjects with Grade I Hypertension and Antihypertensive Drug Therapy: A Randomized, Triple-Blind Controlled Trial. Nutrients, 15.","DOI":"10.3390\/nu15173691"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/wasj.2025.337","article-title":"Garlic as a medicine throughout the ages (Review)","volume":"7","author":"Bachrach","year":"2025","journal-title":"World Acad. Sci. J."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Tudu, C.K., Dutta, T., Ghorai, M., Biswas, P., Samanta, D., Oleksak, P., Jha, N.K., Kumar, M., and Pro\u0107k\u00f3w, J. (2022). Traditional uses, phytochemistry, pharmacology and toxicology of garlic (Allium sativum), a storehouse of di-verse phytochemicals: A review of research from the last decade focusing on health and nutritional implications. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.929554"},{"key":"ref_57","first-page":"1257","article-title":"The antioxidant, aged garlic extract, exerts cytotoxic effects on wild-type and multidrug-resistant human cancer cells by altering mitochondrial permeability","volume":"53","author":"Ohkubo","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_58","first-page":"1574","article-title":"Chemistry of aged garlic: Diversity of constituents in aged garlic extract and their production mechanisms via the combination of chemical and enzymatic reactions","volume":"19","author":"Kodera","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Gasparello, J., Papi, C., Marzaro, G., Macone, A., Zurlo, M., Finotti, A., Agostinelli, E., and Gambari, R. (2024). Aged Garlic Extract (AGE) and Its Constituent S-Allyl-Cysteine (SAC) Inhibit the Expression of Pro-Inflammatory Genes Induced in Bronchial Epithelial IB3-1 Cells by Exposure to the SARS-CoV-2 Spike Protein and the BNT162b2 Vaccine. Molecules, 29.","DOI":"10.20944\/preprints202411.0635.v1"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3892\/etm.2025.12903","article-title":"Aged garlic extract major constituent S-1-propenyl-l-cysteine inhibits proinflammatory mRNA expression in bronchial epi-thelial IB3-1 cells exposed to the BNT162b2 vaccine","volume":"30","author":"Papi","year":"2025","journal-title":"Exp. Ther. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1139\/bcb-2021-0004","article-title":"S-allylcysteine inhibits chondrocyte inflammation to reduce human osteoarthritis via targeting RAGE, TLR4, JNK, and Nrf2 signaling: Comparison with colchicine","volume":"99","author":"Elmazoglu","year":"2021","journal-title":"Biochem. Cell Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0891-5849(97)00006-3","article-title":"S-allyl cysteine inhibits activation of nuclear factor kappa B in human T cells","volume":"23","author":"Geng","year":"1997","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-2006-959461","article-title":"Pharmacokinetics of the garlic compound S-allylcysteine","volume":"60","author":"Nagae","year":"1994","journal-title":"Planta Medica"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"456S","DOI":"10.3945\/jn.114.201749","article-title":"Pharmacokinetics of S-Allyl-l-cysteine in Rats Is Characterized by High Oral Absorption and Extensive Renal Reabsorption","volume":"146","author":"Amano","year":"2016","journal-title":"J. Nutr."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3892\/etm.2025.12852","article-title":"Pharmacokinetics of sulfur-containing compounds in aged garlic extract: S-Allylcysteine, S-1-propenylcysteine, S-methylcysteine, S-allylmercaptocysteine and others (Review)","volume":"29","author":"Nakamoto","year":"2025","journal-title":"Exp. Ther. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejphar.2008.01.032","article-title":"Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis in-hibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages","volume":"584","author":"Kim","year":"2008","journal-title":"Eur. J. Phar-macol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/039463201102400208","article-title":"Eugenolol and glyceryl-isoeugenol suppress LPS-induced iNOS expression by down-regulating NF-kappaB AND AP-1 through inhibition of MAPKS and AKT\/IkappaBalpha signaling pathways in macrophages","volume":"24","author":"Yeh","year":"2011","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/jcb.24062","article-title":"Euscaphic acid isolated from roots of Rosa rugosa inhibits LPS-induced inflammatory responses via TLR4-mediated NF-\u03baB inactivation in RAW 264.7 macrophages","volume":"113","author":"Kim","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.intimp.2016.08.021","article-title":"Cnidilide, an alkylphthalide isolated from the roots of Cnidium officinale, suppresses LPS-induced NO, PGE2, IL-1\u03b2, IL-6 and TNF-\u03b1 production by AP-1 and NF-\u03baB inactivation in RAW 264.7 macrophages","volume":"40","author":"Lee","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Li, H.Y., Tong, L., Zhao, Q., and He, Q.L. (2025). Natural products targeting the NF-\u03baB signaling pathway: Potential therapeutic drug candidates. Bioorg Med. Chem. Lett., 128.","DOI":"10.1016\/j.bmcl.2025.130319"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Wu, J., Liu, X., Chen, X., and Wang, J. (2025). Decoding nature: Multi-target anti-inflammatory mechanisms of natural products in the TLR4\/NF-\u03baB pathway. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1467193"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"104","DOI":"10.31662\/jmaj.2023-0009","article-title":"Roles of MicroRNAs in Disease Biology","volume":"6","author":"Suzuki","year":"2023","journal-title":"JMA J."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Matsuyama, H., and Suzuki, H.I. (2019). Systems and Synthetic microRNA Biology: From Biogenesis to Disease Pathogenesis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21010132"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","article-title":"MicroRNAs in action: Biogenesis, function and regulation","volume":"24","author":"Shang","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2008","journal-title":"Genome Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrg3965","article-title":"Towards a molecular understanding of microRNA-mediated gene silencing","volume":"16","author":"Jonas","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Hanna, J., Hossain, G.S., and Kocerha, J. (2019). The Potential for microRNA Therapeutics and Clinical Research. Front. Genet., 10.","DOI":"10.3389\/fgene.2019.00478"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Momin, M.Y., Gaddam, R.R., Kravitz, M., Gupta, A., and Vikram, A. (2021). The Challenges and Opportunities in the Development of MicroRNA Therapeutics: A Multidisciplinary Viewpoint. Cells, 10.","DOI":"10.3390\/cells10113097"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41467-017-00972-z","article-title":"An NF-kappaB-microRNA regulatory network tunes macrophage inflammatory responses","volume":"8","author":"Mann","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Ghafouri-Fard, S., Abak, A., Shoorei, H., Talebi, S.F., Mohaqiq, M., Sarabi, P., Taheri, M., and Mokhtari, M. (2021). Interaction between non-coding RNAs and Toll-like receptors. Biomed. Pharmacother., 140.","DOI":"10.1016\/j.biopha.2021.111784"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"482","DOI":"10.5114\/ceji.2018.81351","article-title":"Regulation of TLR signaling pathways by microRNAs: Implications in inflammatory diseases","volume":"43","year":"2018","journal-title":"Cent. Eur. J. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Xi, M., Zhao, P., Li, F., Bao, H., Ding, S., Ji, L., and Yan, J. (2022). MicroRNA-16 inhibits the TLR4\/NF-kappaB pathway and maintains tight junction integrity in irritable bowel syndrome with diarrhea. J. Biol. Chem., 298.","DOI":"10.1016\/j.jbc.2022.102461"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1165\/rcmb.2013-0160OC","article-title":"Expression of microRNA-93 and interleukin-8 during pseudomonas aeruginosa-mediated induction of proinflammatory responses","volume":"50","author":"Fabbri","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"119947","DOI":"10.1016\/j.jep.2025.119947","article-title":"Qingfei Litan decoction alleviated Klebsiella pneumoniae-induced pneumonia by targeting the TLR4\/MyD88\/NF-kappaB axis via miR-146a-5p","volume":"349","author":"Wei","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"ref_87","first-page":"29","article-title":"MicroRNA-329-3p alleviates high glucose-induced endothelial cell injury via inhibition of the TLR4\/TRAF6\/NF-\u03baB signaling pathway","volume":"21","author":"Song","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3892\/etm.2021.10176","article-title":"MiR-489-3p inhibits TLR4\/NF-kappaB signaling to prevent inflammation in psoriasis","volume":"22","author":"Ye","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ibd\/izab132","article-title":"Immunomodulatory Effect of Serum Exosomes From Crohn Disease on Macro-phages via Let-7b-5p\/TLR4 Signaling","volume":"28","author":"Gong","year":"2022","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jid.2018.11.007","article-title":"A MicroRNA-29 Mimic (Remlarsen) Represses Extracellular Matrix Expression and Fibroplasia in the Skin","volume":"139","author":"Piper","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Kara, G., Arun, B., Calin, G.A., and Ozpolat, B. (2022). MiRacle of microRNA-Driven Cancer Nanotherapeutics. Cancers, 14.","DOI":"10.3390\/cancers14153818"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3892\/ijmm.2020.4610","article-title":"MicroRNA-93 contributes to the suppression of lung inflammatory responses in LPS-induced acute lung injury in mice via the TLR4\/MyD88\/NF-\u03baB signaling pathway","volume":"46","author":"Gao","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.febslet.2014.03.013","article-title":"MicroRNA-93 inhibits inflammatory cytokine production in LPS-stimulated murine macrophages by targeting IRAK4","volume":"588","author":"Xu","year":"2014","journal-title":"Febs Lett."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.3892\/etm.2017.4874","article-title":"MicroRNA-93 inhibits inflammatory responses and cell apoptosis after cerebral ischemia reperfusion by targeting interleukin-1 receptor-associated kinase 4","volume":"14","author":"Tian","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_96","first-page":"3","article-title":"Gambari R Perspectives in MicroRNA Therapeutics for Cystic Fibrosis","volume":"11","author":"Finotti","year":"2025","journal-title":"Noncoding RNA"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3892\/etm.2025.12884","article-title":"Potential applications of components of Aged Garlic Extract (AGE) in mitigating pro-inflammatory gene expression linked to human diseases","volume":"30","author":"Agostinelli","year":"2025","journal-title":"Exp. Ther. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3892\/etm.2025.12835","article-title":"Preliminary results and a theoretical perspective of co-treatment using a miR-93-5p mimic and aged garlic extract to inhibit the expression of the pro-inflammatory interleukin-8 gene","volume":"29","author":"Gambari","year":"2025","journal-title":"Exp. Ther. Med."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jcf.2004.05.040","article-title":"Established cell lines used in cystic fibrosis research","volume":"3","author":"Gruenert","year":"2004","journal-title":"J. Cyst. Fibros."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Awatade, N.T., Wong, S.L., Hewson, C.K., Fawcett, L.K., Kicic, A., Jaffe, A., and Waters, S.A. (2018). Human Primary Epithelial Cell Models: Promising Tools in the Era of Cystic Fibrosis Personalized Medicine. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.01429"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43556-023-00160-0","article-title":"Delivery of nucleic acids using nanomaterials","volume":"4","author":"Qin","year":"2023","journal-title":"Mol. Biomed."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1089\/jamp.2017.1364","article-title":"Hybrid Lipid\/Polymer Nanoparticles for Pulmonary Delivery of siRNA: Development and Fate Upon In Vitro Deposition on the Human Epithelial Airway Barrier","volume":"31","author":"Costabile","year":"2018","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"103729","DOI":"10.1016\/j.drudis.2023.103729","article-title":"Advanced pulmonary drug delivery formulations for the treatment of cystic fibrosis","volume":"28","author":"Parihar","year":"2023","journal-title":"Drug Discov. Today"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/21\/4155\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T02:07:00Z","timestamp":1761185220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/21\/4155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":103,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["molecules30214155"],"URL":"https:\/\/doi.org\/10.3390\/molecules30214155","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]}}}